United Kingdom Statutory Instruments

(a) In the appropriate alphabetical place in the table having regard to the name of the drug, insert respectively in columns 1, 2 and 3 - 



"Oseltamivir (Tamiflu)	(1) At-risk adult and child patients where -  (a) It has been determined in accordance with a community based virological surveillance scheme that influenza A or influenza B is circulating in the locality in which the patient resides or is present or was present at the time that the virus was circulating; (b) the patient has an influenza-like illness; and (c) the patient can start therapy within 48 hours of the onset of symptoms.	Treatment of influenza
	(2) At-risk patients aged 13 years and older where -  (a) It has been determined in accordance with a community based virological surveillance scheme that influenza A or influenza B is circulating in the locality in which the patient resides; (b) the patient has been exposed to an influenza-like illness through being in close contact with someone with whom he lives who is or has been suffering from an influenza-like illness; (c) the patient is not effectively protected by vaccination against influenza because -  (i) he has not been vaccinated because vaccination is contraindicated; (ii) he has not been vaccinated since the previous influenza season; (iii) he has been vaccinated but it has yet to take effect; or (iv) he has been vaccinated but the vaccine is not well matched to the strain of influenza circulating in the locality in which the patient resides or is or has been present; (d) the patient lives in a residential care establishment and another resident or member of staff of the establishment has an influenza-like illness; and (e) the patient can start prophylaxis within 48 hours of exposure to an influenza-like illness.	Prophylaxis of influenza

"; and

"Zanamivir (Relenza)

At-risk adult patients where -  (a) It has been determined in accordance with a community based virological surveillance scheme that influenza A or influenza B is circulating in the locality in which the patient resides or is present or was present at the time that the virus was circulating; (b) the patient has an influenza-like illness; and (c) the patient can start therapy within 48 hours of the onset of symptoms.

Treatment of influenza

".

(d) After the words "in this Schedule - " insert in the appropriate alphabetical place - 

" " at-risk" means an adult or child patient or a patient over the age of 13 who - 
(a) has chronic respiratory disease (including asthma and chronic obstructive pulmonary disease);

(b) has significant cardiovascular disease, excluding an adult or child patient who has hypertension only;

(c) has chronic renal disease;

(d) are immunocompromised;

(e) has diabetes mellitus; or

(f) is aged 65 years or over;";

"child" means any person under the age of 16;";